Warfarin pharmacology, clinical management, and evaluation of hemorrhagic risk for the elderly

Laurie G. Jacobs

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

Elderly patients as a group may present more of a challenge in managing warfarin therapy because of alterations in pharmacokinetics from other medications, diet, and disease; pharmacodynamic changes; increased risk for hemorrhage; and difficulty in monitoring. The elderly, however, may derive the most benefit from warfarin therapy for certain indications, such as the prevention of stroke in atrial fibrillation or recurrent events following deep venous thrombosis, because their risk of thromboembolic disease is often significantly greater than that observed in other populations. Warfarin can be managed as effectively as in other populations with careful attention to these issues.

Original languageEnglish (US)
Pages (from-to)17-32
Number of pages16
JournalClinics in Geriatric Medicine
Volume22
Issue number1
DOIs
StatePublished - Feb 2006

Fingerprint

Clinical Pharmacology
Warfarin
Venous Thrombosis
Atrial Fibrillation
Population
Pharmacokinetics
Stroke
Hemorrhage
Diet
Therapeutics

ASJC Scopus subject areas

  • Geriatrics and Gerontology

Cite this

Warfarin pharmacology, clinical management, and evaluation of hemorrhagic risk for the elderly. / Jacobs, Laurie G.

In: Clinics in Geriatric Medicine, Vol. 22, No. 1, 02.2006, p. 17-32.

Research output: Contribution to journalArticle

@article{5c6dc719bbdd4c67b9771fbcdd8c3714,
title = "Warfarin pharmacology, clinical management, and evaluation of hemorrhagic risk for the elderly",
abstract = "Elderly patients as a group may present more of a challenge in managing warfarin therapy because of alterations in pharmacokinetics from other medications, diet, and disease; pharmacodynamic changes; increased risk for hemorrhage; and difficulty in monitoring. The elderly, however, may derive the most benefit from warfarin therapy for certain indications, such as the prevention of stroke in atrial fibrillation or recurrent events following deep venous thrombosis, because their risk of thromboembolic disease is often significantly greater than that observed in other populations. Warfarin can be managed as effectively as in other populations with careful attention to these issues.",
author = "Jacobs, {Laurie G.}",
year = "2006",
month = "2",
doi = "10.1016/j.cger.2005.09.001",
language = "English (US)",
volume = "22",
pages = "17--32",
journal = "Clinics in Geriatric Medicine",
issn = "0749-0690",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - Warfarin pharmacology, clinical management, and evaluation of hemorrhagic risk for the elderly

AU - Jacobs, Laurie G.

PY - 2006/2

Y1 - 2006/2

N2 - Elderly patients as a group may present more of a challenge in managing warfarin therapy because of alterations in pharmacokinetics from other medications, diet, and disease; pharmacodynamic changes; increased risk for hemorrhage; and difficulty in monitoring. The elderly, however, may derive the most benefit from warfarin therapy for certain indications, such as the prevention of stroke in atrial fibrillation or recurrent events following deep venous thrombosis, because their risk of thromboembolic disease is often significantly greater than that observed in other populations. Warfarin can be managed as effectively as in other populations with careful attention to these issues.

AB - Elderly patients as a group may present more of a challenge in managing warfarin therapy because of alterations in pharmacokinetics from other medications, diet, and disease; pharmacodynamic changes; increased risk for hemorrhage; and difficulty in monitoring. The elderly, however, may derive the most benefit from warfarin therapy for certain indications, such as the prevention of stroke in atrial fibrillation or recurrent events following deep venous thrombosis, because their risk of thromboembolic disease is often significantly greater than that observed in other populations. Warfarin can be managed as effectively as in other populations with careful attention to these issues.

UR - http://www.scopus.com/inward/record.url?scp=29244465053&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=29244465053&partnerID=8YFLogxK

U2 - 10.1016/j.cger.2005.09.001

DO - 10.1016/j.cger.2005.09.001

M3 - Article

C2 - 16377465

AN - SCOPUS:29244465053

VL - 22

SP - 17

EP - 32

JO - Clinics in Geriatric Medicine

JF - Clinics in Geriatric Medicine

SN - 0749-0690

IS - 1

ER -